Skip to main content

CJC-1295 Ipamorelin Protocol

Meaning

The CJC-1295 Ipamorelin Protocol is a specific therapeutic regimen involving the co-administration of two synthetic peptides: CJC-1295, a Growth Hormone-Releasing Hormone (GHRH) analog, and Ipamorelin, a Growth Hormone Secretagogue (GHS). This combination therapy is designed to stimulate the pituitary gland to produce and release endogenous growth hormone (GH) in a pulsatile, more physiological manner. Clinically, the protocol is utilized in the hormonal health space to enhance lean body mass, improve sleep quality, and support overall cellular regeneration.